Sale!

GP1BA Gene Bernard-Soulier Syndrome Type A2 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The GP1BA Gene Bernard-Soulier Syndrome Type A2 NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the GP1BA gene responsible for Bernard-Soulier Syndrome Type A2. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to detect genetic variations that cause this rare inherited bleeding disorder. Patients experiencing unexplained bruising, prolonged bleeding, or abnormal platelet function should consider this test for accurate diagnosis and proper management. The test provides crucial information for genetic counseling, family planning, and personalized treatment approaches. Results are typically available within 3-4 weeks from sample collection. This advanced genetic analysis is available for $500 USD, offering significant savings from the regular $700 price. Early detection through this test can lead to better management strategies and improved quality of life for affected individuals.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

GP1BA Gene Bernard-Soulier Syndrome Type A2 NGS Genetic DNA Test

Comprehensive Genetic Testing for Inherited Bleeding Disorders

The GP1BA Gene Bernard-Soulier Syndrome Type A2 NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for individuals and families affected by inherited bleeding disorders. This advanced testing methodology provides precise identification of mutations in the GP1BA gene, which plays a critical role in platelet function and blood clotting processes. Bernard-Soulier Syndrome Type A2 is a rare autosomal recessive disorder characterized by giant platelets, thrombocytopenia, and prolonged bleeding time, making accurate genetic diagnosis essential for proper clinical management.

What This Test Measures and Detects

This sophisticated genetic test utilizes Next-Generation Sequencing (NGS) technology to comprehensively analyze the GP1BA gene for pathogenic variants. The test specifically identifies:

  • Point mutations, deletions, and insertions in the GP1BA gene
  • Genetic variations affecting glycoprotein Ib-IX-V complex formation
  • Mutations that disrupt platelet adhesion and aggregation
  • Inheritance patterns for family risk assessment
  • Carrier status identification in unaffected family members

Who Should Consider This Genetic Test

This test is particularly recommended for individuals presenting with the following symptoms or clinical indications:

  • Unexplained bruising or petechiae
  • Prolonged bleeding from minor injuries
  • Excessive bleeding during surgical procedures
  • Heavy menstrual bleeding in females
  • Family history of bleeding disorders
  • Abnormal platelet count or morphology
  • Previous diagnosis of thrombocytopenia with giant platelets
  • Couples planning pregnancy with family history of bleeding disorders

Significant Benefits of Genetic Testing

Undergoing the GP1BA Gene Bernard-Soulier Syndrome Type A2 NGS Genetic DNA Test offers numerous advantages:

  • Accurate Diagnosis: Provides definitive genetic confirmation of Bernard-Soulier Syndrome Type A2
  • Personalized Treatment: Enables tailored management strategies based on specific genetic findings
  • Family Planning: Offers crucial information for genetic counseling and reproductive decisions
  • Early Intervention: Facilitates proactive management before serious bleeding complications occur
  • Carrier Detection: Identifies asymptomatic carriers within families
  • Peace of Mind: Reduces uncertainty and provides clear answers about genetic status

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our expert genetic counselors and medical professionals. Results typically fall into three categories:

  • Positive Result: Indicates the presence of pathogenic mutations in the GP1BA gene, confirming Bernard-Soulier Syndrome Type A2 diagnosis
  • Negative Result: Suggests no disease-causing mutations were detected in the GP1BA gene
  • Variant of Uncertain Significance: Identifies genetic changes whose clinical significance requires further investigation

All positive results include detailed interpretation and recommendations for clinical management. Our genetic counseling team provides comprehensive support to help you understand your results and their implications for your health and family.

Test Pricing Information

Price Type Amount (USD)
Discount Price $500
Regular Price $700

Nationwide Testing Availability

We proudly offer comprehensive genetic testing services across the United States with convenient locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, high-quality results regardless of your location.

Take Control of Your Genetic Health Today

Don’t let uncertainty about genetic bleeding disorders affect your quality of life. Our experienced team is ready to guide you through the testing process and provide the answers you need. With a simple blood sample or extracted DNA, you can gain valuable insights into your genetic health and make informed decisions about your medical care.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your GP1BA Gene Bernard-Soulier Syndrome Type A2 NGS Genetic DNA Test and take the first step toward understanding your genetic health.

Our dedicated genetic counselors are available to discuss your testing options, answer questions about the procedure, and help you prepare for your results. Early detection and proper management can significantly improve outcomes for individuals with inherited bleeding disorders.